Dapagliflozin mitigates cellular stress and inflammation through PI3K/AKT pathway modulation in cardiomyocytes, aortic endothelial cells, and stem cell-derived β cellsFatmah R. Alsereidi, Mohamed A. Saleh, Tiana Salomon et al.|Cardiovascular Diabetology|2024Cited by 50
Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvementFatmah R. Alsereidi, Mohamed A. Saleh, Anamika Gupta et al.|Current Problems in Cardiology|2024Cited by 40